Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
Sobha SivaprasadLaser and Retinal Research Unit, King’s College Hospital, UKAbstract: Age-related macular degeneration (AMD) is responsible for more than half the blind registration in the United Kingdom. Retinal manifestations of AMD can be categorized as either atrophic or neovascula...
Enregistré dans:
Auteur principal: | Sobha Sivaprasad |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e50ab6501f274d3192e46e87d9713aef |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
par: Sobha Sivaprasad, et autres
Publié: (2008) -
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
par: Nikolaus Feucht, et autres
Publié: (2008) -
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
par: Roopa Vemala, et autres
Publié: (2010) -
Treatment of neovascular age-related macular degeneration in patients with diabetes
par: Michael Cummings, et autres
Publié: (2008) -
Treatment of neovascular age-related macular degeneration: Current therapies
par: Albert J Augustin, et autres
Publié: (2009)